文献速递系统性红斑狼疮

使用TYK2抑制剂调节T细胞表型及其对系统性红斑狼疮治疗的意义

Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.
PubMed 文献 · RMD Open · 2024-06-13

研究利用系统性红斑狼疮(SLE)患者外周血样本,发现Tfh1细胞增多且活化Treg细胞相对减少,该失衡在狼疮肾炎尤其III、IV型活动性肾炎中显著;TYK2抑制剂可抑制Tfh1分化而保留IL-2诱导的Treg分化,与JAK抑制剂不同。

要点

  • SLE患者外周血Tfh1细胞增多,活化Treg细胞相对减少,Tfh/Treg失衡在狼疮肾炎尤其III、IV型活动性肾炎中显著。
  • Tfh1细胞可诱导T-bet+ B细胞产生,可能参与SLE发病相关过程。
  • TYK2抑制剂抑制Tfh1分化并维持Treg分化,保留IL-2信号,不同于其他JAK抑制剂。

核心结论

  • Tfh1细胞可诱导T-bet+ B细胞产生,可能参与SLE发病相关过程。
  • TYK2抑制剂可能通过抑制Tfh1分化并维持Treg细胞分化来精细调节免疫失衡,从而保留IL-2信号,不同于其他JAK抑制剂。

研究设计与样本

  • 研究分析未经治疗的SLE患者和健康对照的外周血单个核细胞。
  • 在肾炎组织中鉴定Tfh1细胞,并通过将初始B细胞与Tfh1细胞共培养来检测Tfh1细胞对B细胞分化的影响。
  • 利用记忆CD4+ T细胞进行JAK/TYK2依赖性STAT磷酸化实验。

主要发现

  • 患者外周血中Tfh1细胞数量增加,活化Treg细胞计数相对Tfh1细胞计数减少。
  • Tfh/Treg比值失衡在狼疮肾炎病例中尤为显著,尤其是III型和IV型活动性肾炎。
  • 免疫组化显示狼疮肾炎组织中有Tfh1细胞浸润。
  • 将健康个体的Tfh1细胞与初始B细胞共培养,比对照诱导产生更多的T-bet+ B细胞。
  • 在记忆CD4+ T细胞的STAT磷酸化实验中,IL-12诱导的STAT1/4磷酸化和Tfh1细胞分化被JAK和TYK2抑制剂共同抑制;而IL-2诱导的STAT5磷酸化和IL-2+TGFβ诱导的Treg细胞分化被JAK抑制剂抑制,但未被TYK2抑制剂抑制,提示TYK2不介导IL-2信号通路。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The tuning effects of JAK/TYK2 inhibitors on the imbalance between T follicular helper (Tfh) and T regulatory (Treg) cells, related to systemic lupus erythematosus (SLE) pathogenesis, were investigated using human peripheral blood samples. METHODS: Peripheral blood mononuclear cells from untreated patients with SLE and healthy controls were analysed. Tfh1 cells were identified in nephritis tissue, and the effect of Tfh1 cells on B-cell differentiation was examined by coculturing naïve B cells with Tfh1 cells. RESULTS: Tfh1 cell numbers were increased in the peripheral blood of patients, and activated Treg cell counts were decreased relative to Tfh1 cell counts. This imbalance in the Tfh to Treg ratio was remarkably pronounced in cases of lupus nephritis, especially in types III and IV active nephritis. Immunohistochemistry revealed Tfh1 cell infiltration in lupus nephritis tissues. Co-culture of Tfh1 cells (isolated from healthy individuals) with naïve B cells elicited greater induction of T-bet+ B cells than controls. In JAK/TYK2-dependent STAT phosphorylation assays using memory CD4+ T cells, IL-12-induced STAT1/4 phosphorylation and Tfh1 cell differentiation were inhibited by both JAK and TYK2 inhibitors. However, phosphorylation of STAT5 by IL-2 and induction of Treg cell differentiation by IL-2+TGFβ were inhibited by JAK inhibitors but not by TYK2 inhibitors, suggesting that TYK2 does not mediate the IL-2 signalling pathway. CONCLUSIONS: Tfh1 cells can induce T-bet+ B cell production and may contribute to SLE pathogenesis-associated processes. TYK2 inhibitor may fine-tune the immune imbalance by suppressing Tfh1 differentiation and maintaining Treg cell differentiation, thereby preserving IL-2 signalling, unlike other JAK inhibitors.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Satoh-Kanda Y, Nakayamada S, Kubo S, et al. Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD Open. 2024. PMID: 38871479. doi:10.1136/rmdopen-2023-003991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。